This is good news: A cocktail of synthetic antibodies has shown promising, early results for beating back the coronavirus in patients that aren’t yet seriously ill.  

COVID-19 deaths passed the 1 million mark yesterday, just 9 months into the pandemic:

Sweet relief for testing systems dogged by delays: A $5 test that can diagnose COVID-19 in 30 minutes or less—without specialized staff or medical equipment, 

Big news: A pair of new papers confirm scientists’ hunch that the body’s “vanguard virus fighter”—type I interferon—is out of action in severe COVID-19 cases.  

While Africa’s COVID-19 cases have remained lower than projected, the pandemic has had major indirect impacts, according to a new 

The CDC’s shifting guidelines on airborne transmission of SARS-CoV-2 have real and immediate consequences for front-line health workers, The Guardian reports.

More than 100,000 Chinese citizens have already been given a COVID-19 vaccine before safety trials were completed, a state-owned company behind 3 vaccine candidates said Monday, Vox report

AstraZeneca paused its Phase 3 COVID-19 vaccine trial, citing a suspected adverse reaction in one UK participant and an “abundance of caution.” A standard review process triggered the hold, AstraZeneca said. It didn't share details but noted the illness could be unrelated…

US physicians, state officials, and others are blasting the quietly revised CDC testing guidance that says contacts of infected people do not need to get tested if they don’t have symptoms, 

The first known COVID-19 reinfection has been reported in Hong Kong, underscoring big questions about immunity and whether an eventual vaccine may require booster shots,